as on October 24, 2025 at 1:28 am IST
Day's Low
Day's High
25.00%
Downside
25.00%
Upside
52 Week's Low
52 Week's High
-13.00%
Downside
3075.00%
Upside
Check Carisma Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Carisma Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $- | NA | NA | 0.00% | |
| BUY | $60.9B | 251.94% | -505.15 | -12.96% | |
| NA | $35.9B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.75% | 30.31 | 31.86% | |
| BUY | $62.0B | -0.71% | 14.73 | 31.37% |
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Carisma Therapeutics Inc. Average target price of $1
Get share price movements and forecasts by analysts on Carisma Therapeutics Inc.
What analysts predicted
96%UPSIDE
Target Price
$1
Current Price
$0.04
Analyzed by
12 Analysts
Target
$1.00
Carisma Therapeutics Inc target price $1, a slight upside of 96% compared to current price of $0.04. According to 12 analysts rating.
Investment in Carisma Therapeutics Inc Shares on INDmoney has dropped by -40.87% over the past 30 days, indicating reduced transactional activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 3.38M → 3.72M (in $), with an average increase of 4.7% per quarter
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 157.0%
Price Dip
![]()
In the last 7 days, CARM stock has moved down by -83.1%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -9.26M → -9.77M (in $), with an average decrease of 5.5% per quarter
| Organisation | Carisma Therapeutics Inc |
| E-voting on shares | Click here to vote |
Carisma Therapeutics Inc share price today is $0.04 as on at the close of the market. Carisma Therapeutics Inc share today touched a day high of $0.05 and a low of $0.03.
Carisma Therapeutics Inc share touched a 52 week high of $1.27 on and a 52 week low of $0.05 on . Carisma Therapeutics Inc stock price today i.e. is closed at $0.04,which is 96.85% down from its 52 week high and -11.50% up from its 52 week low.
Indian investors can start investing in Carisma Therapeutics Inc (CARM) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Carisma Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Carisma Therapeutics Inc share’s latest price of $0.04 as on October 24, 2025 at 1:28 am IST, you will get 250.0000 shares of Carisma Therapeutics Inc. Learn more about
fractional shares .